Skip to main content
OpenTrials
Completed

NCT Number: NCT05941858

Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

This clinical trial evaluates an online Tai Chi intervention to promote smoking cessation among cancer survivors. Tai chi is a practice that involves a series of slow gentle movements and physical postures, a meditative state of mind, and controlled breathing. It is a gentle form of exercise that can be done while sitting or standing and does not involve any medications or medical procedures. Tai chi originated as an ancient martial art in China. Over the years, it has become more focused on health promotion and rehabilitation. The use of Tai Chi may be beneficial for cancer patients who want to quit smoking.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

About this study

Aim 1: The primary objective of this study is to pilot an online Tai Chi intervention promoting smoking cessation among cancer survivors1.

Aim 2: Examine whether an online Tai Chi intervention reduces cigarette dependence among cancer survivors who are aged 21 and are interested in quitting smoking.

Aim 3: Test whether an online Tai Chi intervention increases quit attempts and cessation abstinence among cancer survivors who are aged 21 or older and are interested in quitting smoking.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants participate in an 8-week supervised online WaQi/Tai Chi program. Participants receive standard cessation treatment which includes receiving a document highlighting smoking cessation resources.

ARM II: Participants receive standard cessation treatment which includes receiving a document highlighting smoking cessation resources. Participants also receive an 8-week online Tai Chi self-administered teaching module subscription at the end of the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cancer survivor (i.e., have had a cancer diagnosis)
  • Age 21 years and older
  • English speaking/reading
  • Report smoking tobacco in the past 30 days
  • Report at least moderate interest in quitting smoking (>= 3 on a Likert type scale with 5 being very extremely interested)
  • Can participate in Zoom calls for orientation and intervention
  • Have access to a smartphone or tablet
  • Willing to download a free application (app)
  • Can commit to the 8-weeks intervention (WaQi program)
  • Are not currently or have not regularly practiced Tai Chi in the last 6 months
  • Willing to blow into a device (for carbon monoxide measurements)

Exclusion criteria

  • Non-cancer survivors
  • Patients under 21 years old
  • Non-English speaking/reading
  • Non-smokers in the past 30 days
  • Report lower than moderate interest in quitting smoking (< 3 on a Likert type scale with 5 being very extremely interested)
  • Cannot to participate Zoom calls for orientation and intervention
  • No access to a smartphone or tablet
  • Not willing to download a free app
  • Cannot commit to the intervention
  • Has practiced Tai Chi regularly in the last 6 months
  • Not willing to blow into a device
  • Eligible, but sampling quotas full

Treatment and study plan

Smoking Cessation Intervention

Behavioral

Receive smoking cessation resource document

Other names: Smoking and Tobacco Use Cessation Interventions

Carbon Monoxide Measurement

Procedure

Undergo CO test

Other names: Carbon Monoxide, iCOquit

Internet-Based Intervention

Other

Receive access to WaQi/Tai Chi program

Survey Administration

Other

Ancillary studies

Tai Chi

Other

Practice Tai Chi

Primary outcomes

  1. Smoking cessation

    Time frame: At baseline, 4 weeks after start of intervention, and 1 week, 3 months and 6 months post-intervention

    Will be assessed by the participants in both groups by carbon monoxide (CO) verification and self-administered online surveys.

  2. Quit attempts

    Time frame: Will be assessed by the participants in both groups by CO verification and self-administered online surveys.

    Will be assessed by the participants in both groups by CO verification and self-administered online surveys.

  3. Smoking abstinence

    Time frame: At baseline, 4 weeks after start of intervention, and 1 week, 3 months and 6 months post-intervention

    Will be assessed by the amount of CO in a participant's breath using a portable carbon monoxide monitor, which is synced to the participants' smartphones and will ask participants to complete a brief smoking habit survey.

Secondary outcomes

  1. Cigarette Dependence Scale (12 item)

    Time frame: Up to 6 months post-intervention

    This outcome will be assessed by the participants completing self-administered online survey that includes 12 questions.

  2. Secondary measures that may contribute to smoking

    Time frame: At baseline, 1 week, 3 months and 6 months post-intervention

    Will include measures such as, anxiety and depression, physical activity, and pain. Will be assessed by the participants in both groups by self-administered online surveys.

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

A Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 12, 2023
Registry last updated
Apr 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.